Imperial Brands (ITB) AI Stock Analysis

Imperial Brands

(XETRA:ITB)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Resilient revenue and operating marginsContinued revenue growth alongside healthy EBIT and EBITDA margins indicates that Imperial Brands retains meaningful operating efficiency. Stable profitability provides a durable base for funding brand investment, managing market changes, and absorbing moderate volume pressure over the next several quarters.

Negative Factors

Elevated leverageHigher leverage reduces financial flexibility and leaves more cash flow committed to servicing obligations rather than growth or shareholder returns. A lower equity base can also make the business more sensitive to earnings pressure, refinancing conditions, and unexpected cash outflows.

Imperial Brands (ITB) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 22.01B
Dividend Yield: 5.33%
Average Volume (3M): 35.07K
Price to Earnings (P/E): 13.8
Beta (1Y): 0.05
Revenue Growth: 2.03%
EPS Growth: -30.38%
Country: Germany
Employees: 25,100
Sector: Consumer Defensive
Sector Strength: 62
Industry: Tobacco

Imperial Brands Business Overview & Revenue Model

Company Description

Imperial Brands PLC, together with its subsidiaries, manufactures, imports, markets, and sells tobacco and tobacco-related products in Europe, the Americas, Africa, the Asia, Australasia, and internationally. It offers a range of cigarettes, tobacco...

Imperial Brands Earnings Call Summary

Earnings Call Date:May 11, 2026(Q2-2026)|% Change Since:15.48%|Next Earnings Date:Nov 16, 2026

Earnings Call SentimentPositive

The call presented several concrete operational and financial positives: strong cash generation (GBP 2.6bn over 12 months), high operating cash conversion (98%), confirmed full-year guidance, disciplined pricing that offset volume declines, regional profit growth (Europe +6.5%, AAAACE ex-Australia +10.8%), and measurable strategic transformation progress with committed efficiency targets (GBP 320m). These positives were tempered by identifiable near-term headwinds and one-off costs ( > GBP 50m in H1), a notable H1 shortfall in NGP versus in-year expectations due to promotional timing (NGP losses increased ~GBP 13m in U.S.), accelerated Australia volume declines (~50%) and cash payments related to a legal settlement (GBP 150m in H1 plus GBP 162m to follow). Management reiterated confidence in H2 step-up and maintained guidance. Overall, the weight of the highlights (strong cash, confirmed guidance, clear transformation actions, and NGP market share gains) outweighs the lowlights, which are characterized as manageable, mostly one-off or timing-related, and addressable over H2–FY27.

Positive Updates

Strong cash generation

Generated GBP 2.6 billion of free cash flow on a 12-month basis; operating cash conversion of 98% (12-month basis). Expect at least GBP 2.2 billion of free cash flow for the full year (including cash costs related to legal settlement and strategy).

Negative Updates

One-off impacts reducing H1 performance

One-offs and regional impacts in H1 totaled over GBP 50 million, including tariff impacts in the U.S., accelerated Australia volume declines, and promotional effects in U.S. NGP that reduced net revenue and increased NGP losses by ~GBP 13 million.

Company Guidance

The company reiterated full‑year guidance, expecting tobacco net revenue growth in the low single digits and double‑digit NGP net revenue growth, adjusted operating profit growth within the mid‑term target range of 3%–5%, and at least high‑single‑digit EPS growth; it expects at least GBP 2.2bn of free cash flow (having generated GBP 2.6bn over the past 12 months) with operating cash conversion at 98% (12‑month basis) and leverage at c.2.4x (targeting the lower end of its range by year‑end). Management confirmed capital returns (ordinary dividend +4% and the GBP 1.45bn evergreen share buyback on track), noted H1 one‑offs of over GBP 50m (including ~GBP 13m NGP promo impact) and disclosed cash costs for the Delaware settlement (GBP 150m paid in H1; ~GBP 162m remaining in roughly equal installments over the next three years), and flagged a potential 0–1% FX headwind to operating profit and EPS.

Imperial Brands Risk Analysis

Imperial Brands disclosed 12 risk factors in its most recent earnings report. Imperial Brands reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.Management of liquidity and financing requirementsQ4, 2021

2.Failure to ensure expected benefits of strategic transformation programmeQ4, 2021

3.Inability to develop, execute and communicate an effective esg strategy in line with expectations of relevant stakeholdersQ4, 2021

Imperial Brands Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:ITB against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:BATS	74Outperform	GBP 98.70B	15.73	13.38%	5.31%	0.70%	110.32%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

* Consumer Defensive Sector Average

Performance Comparison

DE:ITB and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	DE:ITB	Imperial Brands (UK)	35.44	2.43	7.37%
	GB:BATS	British American Tobacco (UK)	4592.00	805.36	21.27%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Imperial Brands AI Stock Analysis